Mapping of catecholaminergic denervation, neurodegeneration, and inflammation in 6-OHDA-treated Parkinson’s disease mice

Abstract Efforts to develop disease-modifying treatments for Parkinson’s disease (PD) have been hindered by the lack of animal models replicating all hallmarks of PD and the insufficient attention to extra-nigrostriatal regions pathologically critical for the prodromal appearance of non-motor sympto...

Full description

Bibliographic Details
Published in:	npj Parkinson's Disease
Main Authors:	Matteo Santoro, Rachel K. Lam, Sarah E. Blumenfeld, Weiqi Tan, Peter Ciari, Emily K. Chu, Nay L. Saw, Daniel Ryskamp Rijsketic, Jennifer S. Lin, Boris D. Heifets, Mehrdad Shamloo
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-02-01
Online Access:	https://doi.org/10.1038/s41531-025-00872-w

Similar Items

Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer’s disease
by: Andrew K. Evans, et al.
Published: (2024-12-01)

Percutaneous renal sympathetic denervation in catecholaminergic polymorphic ventricular tachycardia
by: Tolga Aksu, MD, et al.
Published: (2017-06-01)

Cardiac sympathetic denervation in 6-OHDA-treated nonhuman primates.
by: Valerie Joers, et al.
Published: (2014-01-01)

Cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia in the light of the medical situation in Japan
by: Masayoshi Mori, et al.
Published: (2024-08-01)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
by: Siyan Zhang, et al.
Published: (2020-08-01)

Nonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeys.
by: Valerie Joers, et al.
Published: (2012-01-01)

DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson’s Disease Rat Model
by: Lingyu Zhang, et al.
Published: (2022-01-01)

Case Report: The unrelenting journey—successful resolution of catecholaminergic polymorphic ventricular tachycardia (CPVT) through right cardiac sympathetic denervation in a teenager after left cardiac sympathetic denervation
by: Hei-To Leung, et al.
Published: (2024-12-01)

Tetraspanin (TSP-17) protects dopaminergic neurons against 6-OHDA-induced neurodegeneration in C. elegans.
by: Neda Masoudi, et al.
Published: (2014-12-01)

Effects of nicotine on catecholaminergic neurotransmission in a premotor stage model of Parkinson’s disease
by: Cristina Cosi, et al.
Published: (2025-02-01)

Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective
by: Yannick Vermeiren, et al.
Published: (2020-07-01)

BROWN ALGAE EXTRACT FUCOXANTHIN: IT’S PROTECTIVE ROLE IN 6-OHDA INDUCED MODEL OF PARKINSON’S DISEASE
by: Jiangbangrui Chu, et al.
Published: (2023-10-01)

Diagnosis of Catecholaminergic Polymorphic Ventricular Tachycardia
by: Ekaterina K. Kulbachinskaya, et al.
Published: (2024-09-01)

Management of Catecholaminergic Polymorphic Ventricular Tachycardia
by: Ekaterina K. Kulbachinskaya, et al.
Published: (2024-05-01)

Inflammatory hallmarks in 6-OHDA- and LPS-induced Parkinson's disease in rats
by: Zhanna Oliynyk, et al.
Published: (2023-07-01)

Selective Vulnerability of the Locus Coeruleus Noradrenergic System and its Role in Modulation of Neuroinflammation, Cognition, and Neurodegeneration
by: Andrew K. Evans, et al.
Published: (2022-11-01)

Chronic high-sugar diet in adulthood protects Caenorhabditis elegans from 6-OHDA-induced dopaminergic neurodegeneration
by: Katherine S. Morton, et al.
Published: (2023-11-01)

Catecholaminergic Polymorphic Ventricular Tachycardia
by: Mohamed Abbas, et al.
Published: (2022-10-01)

Afobazole prevents motor function impairment in mice with 6-OHDA induced Parkinsonism
by: I. A. Kadnikov, et al.
Published: (2019-10-01)

Neuroprotective effect of nicorandil in 6-OHDA induced in vitro model of parkinson's disease
by: Ufuk Okkay, et al.
Published: (2022-03-01)

Systemic inflammation biomarkers in 6-OHDA- and LPS-induced Parkinson’s disease in rats
by: Zh. Oliynyk, et al.
Published: (2022-02-01)

Step Sequence is a Critical Gait Parameter of Unilateral 6-OHDA Parkinson's Rat Models
by: Heather A. Baldwin, et al.
Published: (2017-04-01)

Cell fate analysis of embryonic ventral mesencephalic grafts in the 6-OHDA model of Parkinson's disease.
by: Sonya Carvalho Neto, et al.
Published: (2012-01-01)

Anesthetic management for inhibiting sympathetic activation in an adolescent patient diagnosed with catecholaminergic polymorphic ventricular tachycardia and undergoing left cardiac sympathetic denervation: A case report
by: Kyung‐Hwa Kwak, et al.
Published: (2023-07-01)

6-OHDA-Induced Changes in Colonic Segment Contractility in the Rat Model of Parkinson’s Disease
by: Maria Del Pilar Murillo, et al.
Published: (2023-01-01)

EVALUATION OF AUTOPHAGY IN THE RESPIRATORY NUCLEI POST-TREATMENT WITH APOCYNIN IN THE 6-OHDA MODEL OF PARKINSON’S DISEASE
by: Barbara Falquetto, et al.
Published: (2023-10-01)

Intrastriatal Grafting of Chromospheres: Survival and Functional Effects in the 6-OHDA Rat Model of Parkinson's Disease.
by: Alejandra Boronat-García, et al.
Published: (2016-01-01)

Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake.
by: Tanya Chotibut, et al.
Published: (2012-01-01)

Abscisic acid ameliorates motor disabilities in 6-OHDA-induced mice model of Parkinson's disease
by: Mohammad Shabani, et al.
Published: (2023-08-01)

Gait Analysis for Early Detection of Motor Symptoms in the 6-OHDA Rat Model of Parkinson's Disease
by: Jordi Boix, et al.
Published: (2018-03-01)

Behavioral, neural and ultrastructural alterations in a graded-dose 6-OHDA mouse model of early-stage Parkinson's disease
by: Andrea Slézia, et al.
Published: (2023-11-01)

Npas4: a neuronal transcription factor with a key role in social and cognitive functions relevant to developmental disorders.
by: Laurence Coutellier, et al.
Published: (2012-01-01)

Arrhythmogenic Mechanism of Catecholaminergic Polymorphic Ventricular Tachycardia
by: Nian Liu, MD, et al.
Published: (2006-01-01)

Assessment of Serum Levels of Phosphate and Corticosterone as Possible Biomarkers for Early Diagnosis of Parkinson’s Disease in Rats with 6-OHDA-Induced Parkinson
by: Hashem Haghdoost-Yazdi, et al.
Published: (2024-06-01)

Downregulation of eEF1A/EFT3-4 Enhances Dopaminergic Neurodegeneration After 6-OHDA Exposure in C. elegans Model
by: Pawanrat Chalorak, et al.
Published: (2020-04-01)

Effects of crocin on brain oxidative damage and aversive memory in a 6-OHDA model of Parkinson’s disease
by: Z Rajaei, et al.

The effect of water-soluble pristine C60 fullerene on 6-OHDA-induced Parkinson’s disease in rats
by: V. O. Stetska, et al.
Published: (2021-10-01)

Aerobic exercise improves depressive symptoms in the unilateral 6-OHDA-lesioned rat model of Parkinson’s disease
by: Hannah Loughlin, et al.
Published: (2024-06-01)

Fraternine, a Novel Wasp Peptide, Protects against Motor Impairments in 6-OHDA Model of Parkinsonism
by: Andréia Mayer Biolchi, et al.
Published: (2020-08-01)

Effect of potassium channel blocker 4-aminopyridine pretreatment on the 6-OHDA-induced Parkinson's disease in rats
by: M. Sofiabadi, et al.
Published: (2015-06-01)